BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Limsrivilai J, Stidham RW, Govani SM, Waljee AK, Huang W, Higgins PD. Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2017;15:385-392.e2. [PMID: 27645518 DOI: 10.1016/j.cgh.2016.09.012] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 11.2] [Reference Citation Analysis]
Number Citing Articles
1 Beard JA, Franco DL, Click BH. The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care. Curr Gastroenterol Rep 2020;22. [DOI: 10.1007/s11894-020-0744-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Dulai PS, Singh S, Ohno-Machado L, Sandborn WJ. Population Health Management for Inflammatory Bowel Disease. Gastroenterology 2018;154:37-45. [PMID: 29122544 DOI: 10.1053/j.gastro.2017.09.052] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
3 Khan R, Roy N, Ali H, Naeem M, Sakai E. Fecal Microbiota Transplants for Inflammatory Bowel Disease Treatment: Synthetic- and Engineered Communities-Based Microbiota Transplants Are the Future. Gastroenterology Research and Practice 2022;2022:1-9. [DOI: 10.1155/2022/9999925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Askar S, Sakr MA, Alaty WHA, Aufa OM, Kamel SY, Eltabbakh M, Sherief AF, Shamkh MAA, Rashad H. The psychological impact of inflammatory bowel disease as regards anxiety and depression: a single-center study. Middle East Curr Psychiatry 2021;28. [DOI: 10.1186/s43045-021-00154-0] [Reference Citation Analysis]
5 Chiu Y, Racine-Hemmings F, Dufour I, Vanasse A, Chouinard MC, Bisson M, Hudon C. Statistical tools used for analyses of frequent users of emergency department: a scoping review. BMJ Open 2019;9:e027750. [PMID: 31129592 DOI: 10.1136/bmjopen-2018-027750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Perera S, Yang S, Stott-Miller M, Brady J. Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn's Disease. J Health Econ Outcomes Res 2018;6:96-112. [PMID: 32685575 DOI: 10.36469/9791] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Mak LY, Ng SC, Wong IOL, Li MKK, Lo FH, Wong MTL, Leung CM, Tsang SWC, Chan KH, Sze SF, Shan EHS, Lam BCY, Hui AJ, Hung IFN, Leung WK. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis. J Gastroenterol Hepatol 2018;33:141-9. [PMID: 28475813 DOI: 10.1111/jgh.13817] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
8 Galoosian A, Rezapour M, Liu B, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States. Journal of Clinical Gastroenterology 2020;54:e63-72. [DOI: 10.1097/mcg.0000000000001204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Navabi S, Gorrepati VS, Yadav S, Chintanaboina J, Maher S, Demuth P, Stern B, Stuart A, Tinsley A, Clarke K, Williams ED, Coates MD. Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease. Inflamm Bowel Dis 2018;24:2303-8. [PMID: 29788469 DOI: 10.1093/ibd/izy143] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 17.0] [Reference Citation Analysis]
10 Stettner N, Rosen C, Bernshtein B, Gur-Cohen S, Frug J, Silberman A, Sarver A, Carmel-Neiderman NN, Eilam R, Biton I, Pevsner-Fischer M, Zmora N, Brandis A, Bahar Halpern K, Mazkereth R, di Bernardo D, Brunetti-Pierri N, Premkumar MH, Dank G, Nagamani SCS, Jung S, Harmelin A, Erez A. Induction of Nitric-Oxide Metabolism in Enterocytes Alleviates Colitis and Inflammation-Associated Colon Cancer. Cell Rep 2018;23:1962-76. [PMID: 29768197 DOI: 10.1016/j.celrep.2018.04.053] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
11 Berinstein JA, Cohen-Mekelburg SA, Greenberg GM, Wray D, Berry SK, Saini SD, Fendrick AM, Adams MA, Waljee AK, Higgins PDR. A Care Coordination Intervention Improves Symptoms But Not Charges in High-Risk Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00914-9. [PMID: 34461298 DOI: 10.1016/j.cgh.2021.08.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Greywoode R, Ullman T, Keefer L. National Prevalence of Psychological Distress and Use of Mental Health Care in Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac050. [PMID: 35325138 DOI: 10.1093/ibd/izac050] [Reference Citation Analysis]
13 Flicek CB, Sowa NA, Long MD, Herfarth HH, Dorn SD. Implementing Collaborative Care Management of Behavioral Health for Patients with Inflammatory Bowel Disease. Inflamm Intest Dis. [DOI: 10.1159/000521285] [Reference Citation Analysis]
14 Anderson A, Click B, Ramos-Rivers C, Koutroubakis IE, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie A 3rd, Regueiro M, Binion DG. The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018;24:1380-1388. [PMID: 29860492 DOI: 10.1093/ibd/izy040] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
15 Wils P, Caron B, D’amico F, Danese S, Peyrin-biroulet L. Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge. JCM 2022;11:4269. [DOI: 10.3390/jcm11154269] [Reference Citation Analysis]
16 Nguyen NH, Zhang X, Long MD, Sandborn WJ, Kappelman MD, Singh S. Patient-Reported Outcomes and Risk of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases. Dig Dis Sci 2021. [PMID: 34110539 DOI: 10.1007/s10620-021-07082-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, Kim SC, Lawton RC, Murphy SM, Regueiro M, Rubin DT, Engel-Nitz NM, Heller CA. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation. Inflamm Bowel Dis 2020;26:1-10. [PMID: 31112238 DOI: 10.1093/ibd/izz104] [Cited by in Crossref: 142] [Cited by in F6Publishing: 106] [Article Influence: 71.0] [Reference Citation Analysis]
18 Bernstein CN. The Brain-Gut Axis and Stress in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2017;46:839-46. [DOI: 10.1016/j.gtc.2017.08.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
19 Marrie RA, Graff LA, Fisk JD, Patten SB, Bernstein CN. The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time. Inflamm Bowel Dis 2021;27:1285-93. [PMID: 33393632 DOI: 10.1093/ibd/izaa349] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
20 Quinn CC, Chard S, Roth EG, Eckert JK, Russman KM, Cross RK. The Telemedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Clinical Trial: Qualitative Assessment of Participants' Perceptions. J Med Internet Res 2019;21:e14165. [PMID: 31162128 DOI: 10.2196/14165] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
21 Pugliese N, Roda G, Peyrin-biroulet L, Danese S. Emerging therapies for the treatment of ulcerative colitis. Expert Opinion on Emerging Drugs 2020;25:71-9. [DOI: 10.1080/14728214.2020.1737009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Byrne G, Rosenfeld G, Leung Y, Qian H, Raudzus J, Nunez C, Bressler B. Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease. Can J Gastroenterol Hepatol 2017;2017:6496727. [PMID: 29181373 DOI: 10.1155/2017/6496727] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 19.0] [Reference Citation Analysis]
23 Thakur ER, Sansgiry S, Kramer JR, Waljee AK, Gaidos JK, Feagins LA, Govani SM, Dindo L, El-Serag HB, Hou JK. The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1423-8. [PMID: 31728520 DOI: 10.1093/ibd/izz280] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
24 Szigethy EM, Allen JI, Reiss M, Cohen W, Perera LP, Brillstein L, Cross RK, Schwartz DA, Kosinski LR, Colton JB, LaRusso E, Atreja A, Regueiro MD. White Paper AGA: The Impact of Mental and Psychosocial Factors on the Care of Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2017;15:986-97. [PMID: 28300693 DOI: 10.1016/j.cgh.2017.02.037] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 12.4] [Reference Citation Analysis]
25 Wong JJ, Sceats L, Dehghan M, Wren AA, Sellers ZM, Limketkai BN, Bensen R, Kin C, Park KT. Depression and Health Care Use in Patients With Inflammatory Bowel Disease. J Crohns Colitis 2019;13:19-26. [PMID: 30256923 DOI: 10.1093/ecco-jcc/jjy145] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
26 Silva JC, Machado AS, Fernandes C, Carvalho J. Does disease activity explain psychological differences in Inflammatory Bowel Disease? Neurogastroenterology & Motility 2019;32. [DOI: 10.1111/nmo.13775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Hill E, Nguyen NH, Qian AS, Patel S, Chen PL, Tse CS, Singh S. Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients with Inflammatory Bowel Disease: A Nationally Representative Cohort Study. Dig Dis Sci 2022. [PMID: 35503486 DOI: 10.1007/s10620-022-07505-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Bernstein CN, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott J, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease. The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease. Inflamm Bowel Dis 2018;24:1867-75. [PMID: 29668911 DOI: 10.1093/ibd/izy068] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 28.5] [Reference Citation Analysis]
29 Yin AL, Hachuel D, Pollak JP, Scherl EJ, Estrin D. Digital Health Apps in the Clinical Care of Inflammatory Bowel Disease: Scoping Review. J Med Internet Res. 2019;21:e14630. [PMID: 31429410 DOI: 10.2196/14630] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
30 Blaney H, Vu P, Mathew A, Snelling R, England J, Duong C, Hammonds K, Johnson C. Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel Disease. Dig Dis Sci 2021;66:2555-63. [PMID: 32892260 DOI: 10.1007/s10620-020-06590-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kelso M, Feagins LA. Can Smartphones Help Deliver Smarter Care for Patients With Inflammatory Bowel Disease? Inflamm Bowel Dis. 2018;24:1453-1459. [PMID: 29868764 DOI: 10.1093/ibd/izy162] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
32 Berinstein JA, Cohen-Mekelburg SA, Steiner CA, McLeod M, Noureldin M, Allen JI, Kullgren JT, Waljee AK, Higgins PDR. Variations in Health Care Utilization Patterns Among Inflammatory Bowel Disease Patients at Risk for High Medical Service Utilization Enrolled in High Deductible Health Plans. Inflamm Bowel Dis 2021;27:771-8. [PMID: 32676638 DOI: 10.1093/ibd/izaa179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Weaver E, Szigethy E. Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist. Curr Gastroenterol Rep 2020;22:20. [PMID: 32185521 DOI: 10.1007/s11894-020-0757-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
34 Regueiro M, Click B, Anderson A, Shrank W, Kogan J, McAnallen S, Szigethy E. Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home. Clin Gastroenterol Hepatol 2018;16:1777-85. [PMID: 29654918 DOI: 10.1016/j.cgh.2018.04.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 10.8] [Reference Citation Analysis]
35 Choi YI, Park SJ, Chung JW, Kim KO, Cho JH, Kim YJ, Lee KY, Kim KG, Park DK. Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study.J Clin Med. 2020;9:3427. [PMID: 33114505 DOI: 10.3390/jcm9113427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Abu Sneineh A, Haj Ali S, Al-Masri A, Diab A, Aldweik F, Darweesh M, Qaisi M, Alshakhatreh O, Tamimi T, Rayyan Y, Banimustafa R, Sablaban I. Prevalence of anxiety and depressive symptoms in ulcerative colitis patients in Jordan and its relationship to patient-reported disease activity. Sci Rep 2022;12:7682. [PMID: 35538204 DOI: 10.1038/s41598-022-11911-4] [Reference Citation Analysis]
37 Tang MT, Keir ME, Erickson R, Stefanich EG, Fuh FK, Ramirez-Montagut T, McBride JM, Danilenko DM. Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease. Aliment Pharmacol Ther 2018;47:1440-52. [PMID: 29601644 DOI: 10.1111/apt.14631] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
38 Kaur M, Dalal RL, Shaffer S, Schwartz DA, Rubin DT. Inpatient Management of Inflammatory Bowel Disease-Related Complications. Clin Gastroenterol Hepatol. 2020;18:1346-1355. [PMID: 31927105 DOI: 10.1016/j.cgh.2019.12.040] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
39 Long GH, Tatro AR, Oh YS, Reddy SR, Ananthakrishnan AN. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data. Adv Ther 2019;36:3079-95. [PMID: 31562607 DOI: 10.1007/s12325-019-01095-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
40 Kinnucan J, Binion D, Cross R, Evans E, Harlen K, Matarese L, Mullins A, O’neal B, Reiss M, Scott FI, Weaver A, Rosenberg J. Inflammatory Bowel Disease Care Referral Pathway. Gastroenterology 2019;157:242-254.e6. [DOI: 10.1053/j.gastro.2019.03.064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
41 Schwartz DA, Wang A, Ozbay B, Skup M, Eichner SF, Lin J, Chao J. Comparison of Health Care Utilization and Costs Between Patients with Perianal Fistulizing Crohn's Disease Treated with Biologics with or Without Previous Seton Placement. Inflamm Bowel Dis 2017;23:1860-6. [PMID: 28858069 DOI: 10.1097/MIB.0000000000001243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
42 Narula N, Pinto-Sanchez MI, Calo NC, Ford AC, Bercik P, Reinisch W, Moayyedi P. Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1255-61. [PMID: 30615113 DOI: 10.1093/ibd/izy385] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
43 Cohen-Mekelburg S, Saini SD, Krein SL, Hofer TP, Wallace BI, Hollingsworth JM, Bynum JPW, Wiitala W, Burns J, Higgins PDR, Waljee AK. Association of Continuity of Care With Outcomes in US Veterans With Inflammatory Bowel Disease. JAMA Netw Open 2020;3:e2015899. [PMID: 32886122 DOI: 10.1001/jamanetworkopen.2020.15899] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Tanaree A, Assanangkornchai S, McNeil E. Patient predictors of individual cost of integrated treatment program for alcohol problems at community hospitals in southern Thailand. Asian J Psychiatr 2019;43:132-6. [PMID: 31136909 DOI: 10.1016/j.ajp.2019.05.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Ding Z, Patel A, Izanec J, Pericone CD, Lin JH, Baugh CW. Trends in US emergency department visits and subsequent hospital admission among patients with inflammatory bowel disease presenting with abdominal pain: a real-world study from a national emergency department sample database. J Mark Access Health Policy 2021;9:1912924. [PMID: 33968334 DOI: 10.1080/20016689.2021.1912924] [Reference Citation Analysis]
46 Click B, Binion DG, Anderson AM. Predicting Costs of Care for Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2017;15:393-5. [PMID: 27923719 DOI: 10.1016/j.cgh.2016.11.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
47 Shah NB, Haydek J, Slaughter J, Ashton JR, Zuckerman AD, Wong R, Raffa F, Garrett A, Duley C, Annis K, Wagnon J, Gaines L, Dalal R, Scoville E, Beaulieu DB, Schwartz D, Horst SN. Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:314-20. [PMID: 31671188 DOI: 10.1093/ibd/izz253] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
48 Kamp K, Holmstrom A, Luo Z, Wyatt G, Given B. Factors Influencing Received Social Support Among Emerging Adults With Inflammatory Bowel Disease: A Cross-Sectional Study. Gastroenterol Nurs 2020;43:429-39. [PMID: 33055542 DOI: 10.1097/SGA.0000000000000483] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Mayfield CA, Geraci M, Dulin M, Eberth JM, Merchant AT. Social and demographic characteristics of frequent or high-charge emergency department users: A quantile regression application. J Eval Clin Pract 2021. [PMID: 33511747 DOI: 10.1111/jep.13537] [Reference Citation Analysis]
50 El-Matary W, Kuenzig ME, Singh H, Okoli G, Moghareh M, Kumar H, Lê ML, Benchimol EI. Disease-Associated Costs in Children With Inflammatory Bowel Disease: A Systematic Review. Inflamm Bowel Dis 2020;26:206-15. [PMID: 31211827 DOI: 10.1093/ibd/izz120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
51 Melmed GY, Oliver B, Hou JK, Lum D, Singh S, Crate D, Almario C, Bray H, Bresee C, Gerich M, Gerner D, Heagy E, Holthoff M, Hudesman D, McCutcheon Adams K, Mattar MC, Metwally M, Nelson E, Ostrov A, Rubin DT, Scott F, Samir S, van Deen W, Younes Z, Oberai R, Weaver A, Siegel CA; IBD Qorus. Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease. Am J Gastroenterol 2021;116:2410-8. [PMID: 34797226 DOI: 10.14309/ajg.0000000000001547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
52 O'Hagan P, Limdi J, Akbar A, Tucknott S, Kahol DN. Ulcerative colitis: understanding the impact of ulcerative colitis on everyday life and exploring the unmet needs of patients. Curr Med Res Opin 2021;37:1901-11. [PMID: 34420463 DOI: 10.1080/03007995.2021.1971180] [Reference Citation Analysis]
53 Bernstein CN, Hitchon CA, Walld R, Bolton JM, Lix LM, El-Gabalawy R, Sareen J, Singer A, Katz A, Marriott J, Fisk JD, Patten SB, Marrie RA. The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study. Inflamm Bowel Dis 2021;27:1462-74. [PMID: 33274369 DOI: 10.1093/ibd/izaa310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Reja M, Hajela N, Makar M, Marino D, Bhurwal A, Rustgi V. One-year risk of opioid use disorder after index hospitalization for inflammatory bowel disease. Int J Colorectal Dis 2020;35:2081-7. [PMID: 32681379 DOI: 10.1007/s00384-020-03691-y] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Bogale K, Maheshwari P, Kang M, Gorrepati VS, Dalessio S, Walter V, Stuart A, Koltun W, Bernasko N, Tinsley A, Williams ED, Clarke K, Coates MD. Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease. Sci Rep 2022;12:10577. [PMID: 35732802 DOI: 10.1038/s41598-022-14838-y] [Reference Citation Analysis]
56 Wilke T, Groth A, Long GH, Tatro AR, Sun D. Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany. Clin Ther 2020;42:130-143.e3. [PMID: 31883702 DOI: 10.1016/j.clinthera.2019.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
57 Christian K, Cross RK. Improving Outcomes in Patients With Inflammatory Bowel Disease Through Integrated Multi-Disciplinary Care—the Future of IBD Care. Clinical Gastroenterology and Hepatology 2018;16:1708-9. [DOI: 10.1016/j.cgh.2018.07.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Kim JW, Lee CK, Lee JK, Jeong SJ, Oh SJ, Moon JR, Kim HS, Kim HJ. Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006-2015). Scand J Gastroenterol 2019;54:419-26. [PMID: 30905222 DOI: 10.1080/00365521.2019.1591498] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
59 Sheehan JL, Jacob J, Berinstein EM, Greene-Higgs L, Steiner CA, Berry SK, Shannon C, Cohen-Mekelburg SA, Higgins PDR, Berinstein JA. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis 2022:izac021. [PMID: 35230420 DOI: 10.1093/ibd/izac021] [Reference Citation Analysis]
60 Niccum B, Moninuola O, Miller K, Khalili H. Opioid Use Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2021;19:895-907.e4. [PMID: 32835841 DOI: 10.1016/j.cgh.2020.08.041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
61 Azzam NA, Aljebreen A, Almuhareb A, Almadi MA. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients. Saudi J Gastroenterol 2020;26:256-62. [PMID: 32415045 DOI: 10.4103/sjg.SJG_175_20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
62 Schmidt T, Feagins LA. How Can We Improve to Keep Our Patients Out of the Hospital? Inflamm Bowel Dis 2019;25:980-6. [PMID: 30380035 DOI: 10.1093/ibd/izy335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]